SeQuent Scientific Limited (512529) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

SeQuent Scientific Limited (512529) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SeQuent Scientific Limited (512529) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
SeQuent Scientific Limited (512529) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
20 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

SeQuent Scientific Limited (SeQuent) develops and manufactures life science and industrial products. The company's products include aciclovir sodium, albendazole, artemether, artesunate, amyl meta cresol, citicoline sodium, dihydroartemisinin and others. SeQuent provides analytical solutions such as method validation, stability, microbiology. Its products are used in the therapeutic areas of anti-malarial, anthelmintics, anti-infective, antiviral, CNS and dermatology. SeQuent serves API, pharmaceutical, personal care, institutional and nutraceutical companies. The company has facilities in Karnataka, Maharashtra, Andhra Pradesh, and Karnataka, India and Ankara, Turkey.

SeQuent Scientific Limited (512529) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have s

  
Source:
Document ID
GDPH245489D
Country
Industry
Ticker
512529=IN
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
SeQuent Scientific Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
SeQuent Scientific Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
SeQuent Scientific Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
SeQuent Scientific Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
SeQuent Scientific Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
SeQuent Scientific Limited, Pharmaceuticals &Healthcare, Deal Details107
  Asset Purchase101
    Shasun Pharma To Sell Active Pharmaceutical Ingredients Manufacturing Facility101
  Partnerships111
    SeQuent Scientific Forms Joint Venture with Shasun Pharma111
  Licensing Agreements121
    Gilead Sciences Enters into Licensing Agreement with SeQuent Scientific121
  Equity Offering131
    SeQuent Scientific Raises USD8.36 Million in Private Placement of Shares131
  Acquisition141
    SeQuent Scientific to Acquire Remaining Stake in Alivira Animal Health for USD12 Million141
    SeQuent Scientific To Acquire Arvee Syntthesis151
    Sequent Scientific To Acquire Minority Stake In Shasun Pharma For Us$27 Million161
SeQuent Scientific Limited - Key Competitors171
Key Employees181
Locations And Subsidiaries191
  Head Office191
Appendix201
  Methodology201
  About GlobalData201
  Contact Us201
  Disclaimer201

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "SeQuent Scientific Limited (512529) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SeQuent-Scientific-Limited-512529-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-22763>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). SeQuent Scientific Limited (512529) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SeQuent-Scientific-Limited-512529-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-22763>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research